• EORTC 1945 OligoRARE trial
    Categories: ,

    PRESS RELEASE: EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide Foundation

  • lung-x-ray

    PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

  • A. Eggermont - ESMO 2020

    PRESS RELEASE: KEYTRUDA® (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Compared Versus Placebo as Adjuvant Treatment in Resected, High-Risk Stage III Melanoma

  • The brain tumour patients' charter of rights

    PRESS RELEASE: Advocacy Organizations and Professional Societies from Across the Globe Unite on Brain Tumour Patients’ Charter of Rights

  • CDDF - EORTC collaboration
    Categories: ,

    PRESS RELEASE: EORTC and CDDF announce new collaboration

  • Categories: ,

    PRESS RELEASE : Significant PIONEER milestone – First two datasets uploaded into the PIONEER Big Data platform

  • SISAQOL press release - illustration

    PRESS RELEASE: Researchers develop first international standards for quality of life measurement in cancer

  • SISAQOL press release - illustration

    PRESS RELEASE: Study shows importance of Quality of Life scores as prognostic factors in cancer patients